Certificate in Antithrombotics: Cardiovascular Focus
-- ViewingNowThe Certificate in Antithrombotics: Cardiovascular Focus is a comprehensive course designed to equip learners with the essential skills necessary for career advancement in the healthcare industry. This program focuses on antithrombotics, medications that prevent blood clots, and their application in cardiovascular medicine.
2,702+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Introduction to Antithrombotics: Defining antithrombotics, their importance, and how they interact with the cardiovascular system.
⢠Pharmacology of Antithrombotics: Examining the classes of antithrombotics, their mechanisms of action, and key pharmacokinetic and pharmacodynamic properties.
⢠Cardiovascular Diseases: Understanding the pathophysiology, diagnosis, and treatment of various cardiovascular diseases, including coronary artery disease, heart failure, and peripheral artery disease.
⢠Antithrombotics in Atrial Fibrillation: Learning about the role of antithrombotics in managing atrial fibrillation, including the use of direct oral anticoagulants and vitamin K antagonists.
⢠Antithrombotics in Acute Coronary Syndromes: Exploring the use of antithrombotics in acute coronary syndromes, including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction.
⢠Antithrombotics in Peripheral Artery Disease: Examining the role of antithrombotics in managing peripheral artery disease, including the use of antiplatelet therapy and anticoagulation.
⢠Bleeding Risks and Management: Understanding the bleeding risks associated with antithrombotics and strategies for managing bleeding events.
⢠Monitoring and Adjusting Antithrombotic Therapy: Learning about the importance of monitoring and adjusting antithrombotic therapy, including the use of laboratory tests and clinical assessment.
⢠Special Populations and Antithrombotics: Examining the use of antithrombotics in special populations, including elderly patients, patients with renal impairment, and patients with liver disease.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
